OXLUMO® (lumasiran) | Official Patient Website
OXLUMO® (lumasiran) is the first FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 (PH1) by lowering oxalate in urine. See Important Safety …
OXLUMO works by reducing oxalate production - OXLUMO® …
OXLUMO® (lumasiran) is the first FDA‐approved prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood. See Important Safety …
Understanding primary hyperoxaluria type 1 (PH1) - OXLUMO® …
Learn about PH1. OXLUMO® (lumasiran) is the first FDA approved prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood. See …
Starting OXLUMO® (lumasiran)
WHAT IS OXLUMO? OXLUMO is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood in children and adults. For …
OXLUMO® (lumasiran) | Patient Support
You and your doctor will determine if OXLUMO is right for you. What is OXLUMO and how does it work? OXLUMO is a prescription medicine for the treatment of PH1 to lower oxalate in urine …
OXLUMO is a HAO1-directed small interfering ribonucleic acid (siRNA) indicated for the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult …
Alnylam Patient Education Liaisons | OXLUMO® (lumasiran)
Our Alnylam Patient Education Liaisons (Alnylam PELs) can provide patients and families with information about treatment with OXLUMO® (lumasiran) and the condition it treats.
Sign Up for Updates | OXLUMO® (lumasiran)
OXLUMO is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood in children and adults. For additional information about …
OXLUMO® (lumasiran)
OXLUMO® (lumasiran)
Site Map | OXLUMO® (lumasiran)
what is oxlumo? OXLUMO is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood in children and adults. For additional …